Innovation in Clinical Trials: opportunities and challenges

Similar documents
Why do we need an addendum to ICH E6?

The Outcome. Emerging Technologies in Healthcare. Dispatch From a Broken Healthcare System. How it Should Have Worked 11/12/17.

IMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE

PATIENT RECRUITMENT & RETENTION

Addendum to ICH E6 (R2)

OFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records

Patient First Drug Development:

Overview ICH GCP E6(R2) Integrated Addendum

Guidelines for Telemedicine Scheduling and Patient Care Co-ordination

Full Solution Logo. Perioperative Documentation Solution

Technologies in Pharmacology

19/09/2017. Telehealth Legal and Regulatory Issues in Colorado and Beyond. Nathaniel Lacktman, October 2017

Driving Business Value for Healthcare Through Unified Communications

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Roles & Responsibilities of Investigator & IRB

Personal Experience Outcomes and the PEONIES Project: A brief introduction

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

EMERGING TRENDS WHAT I WILL COVER INCREASED INTEREST DEVICES ARE MIGRATING SAFE AND RELIABLE DEVICES LEAD TO LIVING WELL

Integrated Leadership for Hospitals and Health Systems: Principles for Success

Clinical Research Professionals

Recruiting subjects for clinical research outside the academic setting

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Pablo Tebas, M.D. Joseph Quinn, RN, BSN Yan Jiang, RN, BSN, MSN

Guidance for Investigators Subject Recruitment & Retention

Vertex Investigator-Initiated Studies Program Overview

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

Objectives. By the end of this educational encounter, the clinician will be able to:

Copyright 2015 PointClickCare. PointClickCare is a registered trademark.

Residents Rights. Objectives. Introduction

The GCP Perspective on Study Monitoring

European CRO Federation

Research themes for the pharmaceutical sector

SEEKING PATIENT PERSPECTIVES IN CLINICAL TRIAL DESIGN AMY FROMENT, GLOBAL FEASIBILITY OPERATIONS DIR THE PATIENT S VOICE 2017

How/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care?

Personalized Smart Health

The Cost of a Misfiled Medical Document

Managing Privacy Risk in Your Research and Development Enterprise. Sujata Dayal, Abbott Justin McCarthy, Pfizer

Personalized Smart Health

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO

FirstNet Update. John Matovich, FirstNet Solution Consultant

Patient Payment Check-Up

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Toward Greater Scientific Rigor

Good Documentation Practices. Human Subject Research. for

ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan

Standard Operating Procedures

Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE

VitalConnect. Saving lives and enhancing patient care through elegant healthcare solutions.

Digital Disruption meets Indian Healthcare-the role of IT in the transformation of the Indian healthcare system

Health Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues

New Ways of Working - How Cross-Boundary Collaboration is Transforming Business

2017 Clinical Trials Data Library

Center for Health and Technology Telehealth Education Program. Executive Overview

Marketing. Pharmaceutical Industry: Marketing Positions 445

Keeping Your Compliance Program in Pace with Rapidly Expanding TeleHealth Services

Rethinking Telemetry and Its Impact on Healthcare. Wireless technology that improves care and reduces costs

TELEMEDICINE CART/ROBOT PATIENT PORTAL & APP WEARABLE/ MONITORING DEVICE

Conducting Monitoring Visits for Investigator-Initiated Trials (IITs)

Introduction Patient-Centered Outcomes Research Institute (PCORI)

10 Things To Know About

Centers for Medicare & Medicaid Services: Innovation Center New Direction

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

Proposed amendments to the Marihuana for Medical Purposes Regulations

Emerging Roles for Medical Transcription in the Electronic Health Record

Clinical Study Risk Assessment

RESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS

Better Medical Device Data Yield Improved Care The benefits of a national evaluation system

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Latham & Watkins Corporate Department

Take a Course of Action.

IRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today

Value Proposition of the VictoryaHome Project

2017 Oncology Insights

Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center

WORKING TOGETHER WITH PATIENT GROUPS

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016

Training & Resources for Clinical Research Professionals

Rt hon Jeremy Hunt MP Secretary of State for Health and Social Care. Letter by to Dear Jeremy

Work plan for GCP Inspectors Working Group for 2018

Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament

March 31, Consumer Partnership for ehealth s Comments on the draft Shared Nationwide Interoperability Roadmap

Standard Operating Procedures (SOP) Research and Development Office

Lean startup in ehealth

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

ICH Regulators Forum. Dr Peter Arlett EU

Latin America: An Evolving Regulatory Environment September 15, Mapi 2015, All Rights Reserved

Care Plan Management and Visit Verification Using ecare21 Mobile App.

The big-data revolution in US health care: Accelerating value and innovation

BEST PRACTICES FOR DETERMINING FAIR MARKET VALUE FOR ALLIED HEALTH PROFESSIONAL SERVICES

Before the Federal Communications Commission Washington, D.C ) ) ) ) ) ) ) ) REPLY COMMENTS OF THE UNITED STATES TELECOM ASSOCIATION

NICE Charter Who we are and what we do

Big Data NLP for improved healthcare outcomes

Good Clinical Practice: A Ground Level View

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

7/18/2017. Malinda Peeples MS, RN, CDE VP Clinical Advocacy WellDoc Columbia, MD. Disclosure to Participants

Clinic Trial Coordinator

April 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals

Transcription:

Innovation in Clinical Trials: opportunities and challenges Enrica Andreoni Clinical Operations Country Study Manager, Roche SpA FROM - Bergamo - May 27 th, 2014

2 Empowered Patients Are Here

WHY Innovation in Clinical Research? 1. Take opportunities from new communication approaches (social media) 3

4 New Technologies Are Here

2. Take opportunities from new technologies Wearable biosensors/devices have the ability to objectively measure data that has traditionally been self reported by patients or required an office visit (e.g. sleep, activity, vital signs). Biosensors have the ability to provide an early intervention/coaching resulting in enhanced patient compliance and safety oversight in clinical trials. 5

Examples of opportunities from new technologies 6 but it is crucial to pay attention to data reliability and accuracy

7 Value Creation is Here, with the Shifting role of Government and Payers

8 3. Sustain new innovative medicines, developed with high quality in a timely manner and reducing costs

Personalized Medicine is Here 9

10 4. New technologies and new communication approaches could help us to reach easily and quickly our targeted patients for trials

Examples of Tools for Clinical Trial Innovation

12 Websites for Clinical Trials

Social Media & Patient Insights 13

14 Telemedicine & Mobile Home Nursing

15 Biosensors in Clinical Trials

16 Mobile Technology in Clinical Trials

Roche Innovation Overview Selected high impact initiatives Physician Insights Patient Insights Social Media Already available Obtain KOL insights quickly e.g. on identification of indications using online network Sermo Gain patient insights using networks such as Patients Like Me or Crohnology.com design studies which recruit faster Tools to support development of social media recruitment strategies that help accelerate recruitment Mobile Nurse Networks Sharing Trial Results to Patients Site Qualification Training Available in Q3/14 Mobile Nurses could reduce F2F trial visits and increase trial participation/ retention for patients unable to physically visit a trial site Share trial results with patients to foster trust and societal acceptance Establish mutual recognition of GCP training and site qualification between pharmaceutical companies Lean Protocol Design Decentralized Trial mhealth Experiments this year Design significantly more efficient and effective protocols - by starting with a bottoms up strategic firstprinciples approach Enable community doctors and their patients to participate in clinical trials using telemedicine Enable efficient, faster & costeffective development and deployment of mobile app solutions for study teams

Join efforts to improve Clinical Research: TransCelerate 18

19 TransCelerate Mission

TransCelerate ongoing Initiatives 20

Summary: Drug Development Needs Rethink the process increasing patients awareness and patients voice Decreasing costs Apply new technologies New communication approaches (social media) 21 Prepare the ground to accept

Clinical Research Innovation Challenges Tools: reliability & sensitivity Privacy law: differences country by country Regulatory aspects: EMA, FDA, country by country 22

Present & Future Prepare the ground to accept the changes Cultural aspects Regulatory implications Ethics/administrative implication Legal implications (i.e. privacy, advertising, ) Pilot Projects 23

Dream big and make possible! Innovation in clinical trials is a challenging need Innovation is helpful for patients, caregivers, physicians, pharmaceutical companies and governments Innovation could decrease drug development and health assistance costs Innovation means updating regulatory framework preserving three key important topics: 24 PATIENT S SECURITY PATIENT S PRIVACY PATIENT S QUALITY OF DATA

25 Thank you for your attention!

Doing now what patients need next 26